Project Grant R44GM156142

Award Date 8/1/24
Completion Date 2/28/27
Dollars Obligated $2.3M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $358,862 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to GMJ Technologies, Inc., a minority-owned small business, to develop a microfluidic SDS depletion electrophoresis (SDE) interface. This interface will enable direct coupling of capillary electrophoresis with sodium dodecyl sulfate (CE-SDS) to mass spectrometry for improved characterization and quality control of monoclonal...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of their Plasmonic Scattering Microscopy (PSM) technology. PSM is a breakthrough label-free detection system that enables high-throughput, real-time quantification of membrane protein binding kinetics on single cells in their native cellular...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant under CFDA 93.859 (Biomedical Research and Research Training) to Fluidispec LLC in Philadelphia, PA. The goal of this 1-year project is to develop a microfluidic/nanofluidic sample preparation platform to improve protein extraction, purification, and denaturation for both top-down and bottom-up proteomics workflows. This new platform is expected to enhance the depth of proteome coverage and enable...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a Spotting-Free Nano-Oscillator Array (SFNOA) technology for high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. The $349,566 award to Biosensing Instrument Inc., a for-profit manufacturer of scientific instruments based in Tempe, Arizona, aims to...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA Program 93.859 (Biomedical Research and Research Training) is funding research to advance charge detection-mass spectrometry (CD-MS) technology. The primary objectives are to: 1) Improve the mass resolving power of CD-MS above 300,000 by designing enhanced electrostatic linear ion traps (ELITs) and overcoming alignment challenges, and 2) Substantially reduce the time needed to acquire a CD-MS...
The Project Grant award R35GM153179, totaling $939,086 and funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of novel mass spectrometry-based technologies for profiling biomolecular expression at the single-cell level. The key products and services to be delivered under this five-year project include: Developing global and targeted approaches to profile post-translational...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) aims to advance the field of native mass spectrometry (MS) analysis. The $316,825 award to Massmatrix Inc. in Columbus, Ohio will fund the development of an innovative intact mass deconvolution method to significantly improve the speed, accuracy, and user-friendliness of proteins and nucleic acid molecular weight determination using...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $302,417 to Physical Sciences Inc. (PSI), a for-profit R&D company, to develop a novel in-line biomanufacturing process analytical technology tool. The tool will enable real-time monitoring of biomolecules in large-scale bioreactors to support efficient and robust gene therapy biomanufacturing processes. PSI is collaborating...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Zeteo Tech, Inc. in the amount of $271,495.00 on September 30, 2024. The goal of this project is to develop and evaluate a system for fast analysis of antibodies and related macromolecular immune complexes based on a time-of-flight (TOF) mass spectrometer with matrix-assisted laser desorption/ionization (MALDI) ionization. The project...
The National Institute of General Medical Sciences (NIGMS) awarded a $228,000 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the West Virginia University Research Corporation. The objective of this 2-year project is to develop an automated, nanoscale-to-microscale capillary electrophoresis-based system to customize and produce standardized N-glycan structures. The proposed technology will utilize thermally reversible nanogels to sustain and integrate...

This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of a high-resolution native capillary zone electrophoresis system with inline UV and native mass spectrometry capabilities for characterizing charge variants in biologics.

The $2,297,901 award to GMJ Technologies, Inc., a minority-owned small disadvantaged business, aims to address a critical need in the biopharmaceutical industry for efficient analytical tools to characterize and monitor product variants that could impact the safety and efficacy of protein therapeutics. The proposed innovation combines advanced capillary surface chemistry, a novel optical-electrospray interface, and a sensitive nanoflow electrospray mechanism to enable high-resolution separation and native mass spectrometry detection of charge variants in biologics. This solution is expected to improve the efficiency, precision, and sensitivity of analytical workflows for protein therapeutic research, development, and quality control.

Generated 6/10/25, 5:12 AM